- Home
- NRXS vs AEI Comparison
NRXS vs AEI Comparison
Compare NRXS & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- AEI
- Stock Information
- Founded
- NRXS 2011
- AEI 2014
- Country
- NRXS United States
- AEI United States
- Employees
- NRXS N/A
- AEI N/A
- Industry
- NRXS
- AEI Building operators
- Sector
- NRXS
- AEI Real Estate
- Exchange
- NRXS Nasdaq
- AEI Nasdaq
- Market Cap
- NRXS 13.0M
- AEI 10.9M
- IPO Year
- NRXS 2023
- AEI N/A
- Fundamental
- Price
- NRXS $2.60
- AEI $1.06
- Analyst Decision
- NRXS Strong Buy
- AEI
- Analyst Count
- NRXS 1
- AEI 0
- Target Price
- NRXS $7.00
- AEI N/A
- AVG Volume (30 Days)
- NRXS 137.3K
- AEI 115.7K
- Earning Date
- NRXS 08-08-2025
- AEI 08-12-2025
- Dividend Yield
- NRXS N/A
- AEI N/A
- EPS Growth
- NRXS N/A
- AEI N/A
- EPS
- NRXS N/A
- AEI N/A
- Revenue
- NRXS $2,934,945.00
- AEI $16,097,995.00
- Revenue This Year
- NRXS $138,883.78
- AEI N/A
- Revenue Next Year
- NRXS $118.59
- AEI N/A
- P/E Ratio
- NRXS N/A
- AEI N/A
- Revenue Growth
- NRXS 27.52
- AEI N/A
- 52 Week Low
- NRXS $1.33
- AEI $0.70
- 52 Week High
- NRXS $6.20
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- NRXS 52.91
- AEI 56.70
- Support Level
- NRXS $2.32
- AEI $0.98
- Resistance Level
- NRXS $2.65
- AEI $1.30
- Average True Range (ATR)
- NRXS 0.15
- AEI 0.11
- MACD
- NRXS -0.01
- AEI 0.02
- Stochastic Oscillator
- NRXS 78.05
- AEI 52.43
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.